New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
10:17 EDTAMC, SUSS, TLM, PPG, RPM, VAL, SHW, AGU, TPX, SCSS, SU, RKUS, CTIC, CVE, CGEN, ECA, EPGNY, HPTX, ITT, IMO, MERU, BOFIOn The Fly: Analyst Initiation Summary
AMC Entertainment (AMC) initiated with an Equal Weight at Barclays... Canadian Natural (CNQ) initiated with an Outperformer at CIBC... Cell Therapeutics (CTIC) initiated with a Hold at WallachBeth... Cenovus Energy (CVE) initiated with a Sector Performer at CIBC... Compugen (CGEN) initiated with a Buy at Jefferies... Encana (ECA) initiated with a Sector Performer at CIBC... Epigenomics (EPGNY) initiated with a Buy at Maxim... Hyperion Therapeutics (HPTX) initiated with a Buy at Cantor... ITT Corp. (ITT) initiated with a Buy at SunTrust... Imperial Oil (IMO) initiated with a Sector Performer at CIBC... Mattress Firm (MFRM) initiated with a Buy at Jefferies... Meru Networks (MERU) initiated with a Buy at Mizuho... Ruckus Wireless (RKUS) initiated with a Buy at Mizuho... Suncor (SU) initiated with an Outperformer at CIBC... Susser Holdings (SUSS) initiated with a Hold at Jefferies... Talisman Energy (TLM) initiated with an Underperformer at CIBC... PPG Industries (PPG) coverage assumed with an Equal Weight at Morgan Stanley... RPM (RPM) coverage assumed with an Overweight at Morgan Stanley... Valspar (VAL) coverage assumed with an Underweight at Morgan Stanley... Sherwin-Williams (SHW) coverage assumed with an Overweight at Morgan Stanley... Agrium (AGU) coverage resumed with an Equal Weight at Morgan Stanley... Canadian Natural (CNQ) initiated with an Overweight at Morgan Stanley... Tempur Sealy (TPX) initiated with a Neutral at Nomura... Select Comfort (SCSS) initiated with a Neutral at Nomura... Mattress Firm (MFRM) initiated with a Buy at Nomura... Bofi Holding (BOFI) initiated with a Neutral at Sterne Agee.
News For AMC;CTIC;CVE;CGEN;ECA;EPGNY;HPTX;ITT;IMO;MERU;RKUS;SU;SUSS;TLM;PPG;RPM;VAL;SHW;AGU;TPX;SCSS;BOFI From The Last 14 Days
Check below for free stories on AMC;CTIC;CVE;CGEN;ECA;EPGNY;HPTX;ITT;IMO;MERU;RKUS;SU;SUSS;TLM;PPG;RPM;VAL;SHW;AGU;TPX;SCSS;BOFI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 22, 2014
17:53 EDTTLMRepsol exploring bid for Talisman Energy, Bloomberg reports
16:13 EDTBOFIBofI Holding files to sell $50M in common stock
Subscribe for More Information
14:08 EDTECAEarnings Preview: Freeport McMoRan sentiment positive ahead of Q2 report
Subscribe for More Information
10:00 EDTIMOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTVALOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:17 EDTIMOImperial Oil downgraded to Sell from Hold at Canaccord
Canaccord downgraded Imperial Oil to Sell from Hold and said shares are priced to perfection.
05:39 EDTVALValspar upgraded to Conviction Buy from Neutral at Goldman
Goldman Sachs upgraded Valspar to Conviction Buy from Neutral citing the valuation discount peers, the recovery in the U.S. housing market and momentum in the company's Australian business. The firm raised its price target for shares to $97 from $83.
05:27 EDTVALValspar upgraded to Conviction Buy from Neutral at Goldman
July 21, 2014
16:25 EDTAMCPoint72 Asset Management reports 5% passive stake in AMC Entertainment
Subscribe for More Information
06:51 EDTECAEncana poised to sell Deep Panuke project this year, Bloomberg says
Subscribe for More Information
05:12 EDTCTICCTI BioPharma announces approval of Pixuvri in Israel
CTI BioPharma announced that it has received approval from the Israeli Ministry of Health, or MOH, for Pixuvri. Pixuvri in Israel is indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma who have received not more than three previous courses of treatment. The benefit of pixantrone treatment has not been established in patients when used as fifth line or greater chemotherapy in patients who are refractory to last therapy. In Israel, Pixuvri will be distributed and marketed by the Neopharm Group, Israel's second largest pharmaceuticals and health products marketer, once Pixuvri is included in the Israeli National Health Basket of drugs by the MOH. Separately, the Dutch Healthcare Authority, or NZa, and the healthcare insurance board College voor zorgverzekeringen, or CVZ, of the Netherlands have approved funding for Pixuvri as an add-on drug for patients who need a third- or fourth-line treatment option for aggressive B-cell lymphoma. This follows the inclusion of Pixuvri on the HOVON, or Haemato Oncology Foundation for Adults in the Netherlands, treatment guidelines, effective June 1. The inclusion on the Dutch list of reimbursed drugs makes Pixuvri the first registered and reimbursed medicine for the treatment of patients with multiply relapsed or refractory aggressive B-cell NHL in the Netherlands.
July 18, 2014
10:54 EDTSHWSherwin-Williams downgraded to Hold from Buy at Zelman
Subscribe for More Information
09:02 EDTPPGPPG Industries to sell Mt. Zion float glass manufacturing facility
PPG Industries announced that it has reached a definitive agreement to sell substantially all the assets of its Mt. Zion, Illinois, glass manufacturing facility to automotive glass manufacturer Fuyao Glass America Inc. The sale is expected to close in the third quarter 2014, subject to customary closing conditions. Financial terms were not disclosed. The sale of the Mt. Zion facility is consistent with the strategic initiative by PPG’s flat glass business to focus on its higher-technology, coated glass capabilities for residential and commercial construction application.
July 17, 2014
11:41 EDTPPGPPG Industries names Michael McGarry as COO, effective August 1
Subscribe for More Information
08:14 EDTPPGPPG remains 'highly focused' on deploying 'strong' cash position
Subscribe for More Information
08:13 EDTPPGPPG reports Q2 adjusted EPS from cont. ops $2.83, consensus $2.77
Subscribe for More Information
07:05 EDTSHWSherwin-Williams reports Q2 Paint Stores Group sales up 17.2% to $1.88B
Subscribe for More Information
07:04 EDTSHWSherwin-Williams raises FY14 EPS to $8.50-$8.70, consensus $8.49
Sees FY14 net sales growth 8%-13%, consensus $11.13B; This annual guidance includes our expectation that the Comex acquisition will increase net sales by a low single digit percentage in the year and negatively impact diluted net income per common share $.35 per share in 2014.
07:03 EDTSHWSherwin-Williams sees Q3 EPS $3.15-$3.25, consensus $3.06
Subscribe for More Information
07:03 EDTSHWSherwin-Williams reports Q2 EPS $2.94, consensus $2.93
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use